These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9263136

  • 1. Effects of tenidap and nonsteroidal antiinflammatory drugs on the response of cultured human T cells to interleukin 2 in rheumatoid arthritis.
    Hall VC, Wolf RE.
    J Rheumatol; 1997 Aug; 24(8):1467-70. PubMed ID: 9263136
    [Abstract] [Full Text] [Related]

  • 2. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
    Ounissi-Benkalha H, Pelletier JP, Tardif G, Mineau F, Jolicoeur FC, Ranger P, Martel-Pelletier J.
    J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
    [Abstract] [Full Text] [Related]

  • 3. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
    Laliberte R, Perregaux D, Svensson L, Pazoles CJ, Gabel CA.
    J Immunol; 1994 Sep 01; 153(5):2168-79. PubMed ID: 8051418
    [Abstract] [Full Text] [Related]

  • 4. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response.
    Sipe JD, Bartle LM, Loose LD.
    J Immunol; 1992 Jan 15; 148(2):480-4. PubMed ID: 1729367
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs.
    Sanchez C, Mateus MM, Defresne MP, Crielaard JM, Reginster JY, Henrotin YE.
    J Rheumatol; 2002 Apr 15; 29(4):772-82. PubMed ID: 11950021
    [Abstract] [Full Text] [Related]

  • 6. Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
    Munakata Y, Iwata S, Dobers J, Ishii T, Nori M, Tanaka H, Morimoto C.
    Arthritis Rheum; 2000 Jul 15; 43(7):1616-23. PubMed ID: 10902767
    [Abstract] [Full Text] [Related]

  • 7. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
    Blanco FJ, Guitian R, Moreno J, de Toro FJ, Galdo F.
    J Rheumatol; 1999 Jun 15; 26(6):1366-73. PubMed ID: 10381057
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K.
    Arthritis Rheum; 2004 Feb 15; 50(2):432-43. PubMed ID: 14872485
    [Abstract] [Full Text] [Related]

  • 9. Tenidap, but not nonsteroidal anti-inflammatory drugs, inhibits T-cell proliferation and cytokine induction.
    Dolhain RJ, de Kuiper P, Verweij CL, Penders JM, Breedveld FC, Dijkmans BA, Miltenburg AM.
    Scand J Immunol; 1995 Dec 15; 42(6):686-93. PubMed ID: 8552993
    [Abstract] [Full Text] [Related]

  • 10. Nonsteroidal antiinflammatory drugs: effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro.
    Smith RL, Kajiyama G, Lane NE.
    J Rheumatol; 1995 Jun 15; 22(6):1130-7. PubMed ID: 7674242
    [Abstract] [Full Text] [Related]

  • 11. [Duration of use of non-steroidal anti-inflammatory agents in patients with rheumatoid arthritis].
    Luggen ME.
    Rev Rhum Ed Fr; 1994 Dec 15; 61(10 Pt 2):165S-172S. PubMed ID: 7858568
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N, Yamazaki R, Kawai S.
    Arthritis Rheum; 2002 Dec 15; 46(12):3159-67. PubMed ID: 12483719
    [Abstract] [Full Text] [Related]

  • 13. Presence of a population of CD20+, CD38- B lymphocytes with defective proliferative responsiveness in the synovial compartment of patients with rheumatoid arthritis.
    Reparon-Schuijt CC, van Esch WJ, van Kooten C, Ezendam NP, Levarht EW, Breedveld FC, Verweij CL.
    Arthritis Rheum; 2001 Sep 15; 44(9):2029-37. PubMed ID: 11592364
    [Abstract] [Full Text] [Related]

  • 14. The reduced expression of glucocorticoid receptors in synovial cells induced by nonsteroidal antiinflammatory drugs can be reversed by prostaglandin E1 analog.
    Pelletier JP, DiBattista JA, Ranger P, Martel-Pelletier J.
    J Rheumatol; 1994 Sep 15; 21(9):1748-52. PubMed ID: 7799361
    [Abstract] [Full Text] [Related]

  • 15. Tenidap, in contrast to several available nonsteroidal antiinflammatory drugs, potently inhibits the release of activated neutrophil collagenase.
    Blackburn WD, Loose LD, Heck LW, Chatham WW.
    Arthritis Rheum; 1991 Feb 15; 34(2):211-6. PubMed ID: 1847290
    [Abstract] [Full Text] [Related]

  • 16. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
    Summers KL, O'Donnell JL, Heiser A, Highton J, Hart DN.
    Arthritis Rheum; 1999 Mar 15; 42(3):507-18. PubMed ID: 10088774
    [Abstract] [Full Text] [Related]

  • 17. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
    Andrews J, Djakiew D, Krygier S, Andrews P.
    Cancer Chemother Pharmacol; 2002 Oct 15; 50(4):277-84. PubMed ID: 12357301
    [Abstract] [Full Text] [Related]

  • 18. Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells.
    Dezube BJ, Ahlers CM, Lawrence JP, Teng EI, Silberman SL, Pardee AB, Finberg RW.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan 01; 14(1):13-7. PubMed ID: 8989205
    [Abstract] [Full Text] [Related]

  • 19. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis: duration of use as a measure of relative value.
    Luggen ME, Gartside PS, Hess EV.
    J Rheumatol; 1989 Dec 01; 16(12):1565-9. PubMed ID: 2625688
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites.
    Hashimoto K, Lipsky PE.
    J Rheumatol; 1993 Jun 01; 20(6):953-7. PubMed ID: 8350330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.